Drugmakers Ask Supreme Court to Overturn Oregon Drug-Pricing Transparency Law
Pharmaceutical manufacturers have petitioned the U.S. Supreme Court to overturn Oregon's drug-pricing transparency law, arguing it compels companies to justify pricing decisions and expose valuable trade secrets.
Pharmaceutical manufacturers have asked the U.S. Supreme Court to overturn Oregon's drug-pricing transparency law, arguing it forces companies to publicly justify their pricing decisions and give up valuable trade secrets.
The challenge targets the state law's requirement that drugmakers provide public justifications for their pricing. The manufacturers contend that complying with the law would force them to disclose confidential competitive information.